CTRI/2012/04/002589招募中未知
Clinical and Epidemiological Study of EGFR Mutation and EML4-ALK Fusion Gene Among Indian Patients with Adenocarcinoma Lung
Pfizer India0 个研究点目标入组 500 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients known as having an adenocarcinoma histology of NSCLC, already tested for EGFR mutational status and treated over the last 2 years will be considered for this study.
排除标准
- •Non-adenocarcinoma histology of NSCLC
研究者
相似试验
已完成
不适用
a Study of EGFR & ALK Test in Lung cancer patients.CTRI/2017/10/010086Tata Memorial Hospital500
已完成
不适用
Prospective observational study of EGFR mutation allele frequency using Cell free DNAJPRN-UMIN000036149Hamamatsu University School of Medicine33
已完成
不适用
An observational study of EGFR mutation status by circulating tumor DNA during the osimertinib treatment of lung cancer harboring EGFR activating and T790M mutations.lung CancerJPRN-UMIN000025278Miyagi Cancer Center60
招募中
不适用
The continuous evaluation of EGFR mutation in EGFR-mutation positive lung cancer patients during EGFR TKI treatmentnon-small cell lung cancerJPRN-UMIN000037232Advanced Cancer Translational Research Institute100
已完成
不适用
The analysis of significance of EGFR mutations in lung non-adeno and non small cell carcinoma; retrospective multicenter studyEGFR mutations in lung non-adeno and non small cell carcinomaJPRN-UMIN000007294ung Oncology Group in Kyushu, Japan (LOGIK)100